Efficient Gene Delivery into Epstein–Barr Virus (EBV)-Transformed Human B Cells Mediated by Replication-Defective Herpes Simplex Virus-1 (HSV-1): A Gene Therapy Model for EBV-Related B Cell Malignancy

By Suzuki T.   Piche A.   Kasono K.   Xiang J.   Gomez-Navarro J.   Moriuchi S.   Krisky D.M.   Oligino T.   Glorioso J.C.   Curiel T.J.   Curiel D.T.  

Biochemical and Biophysical Research Communications, Vol. 252, Iss. 3, 1998-11 ,pp. : 686-690

Elsevier

Access to resources Recommend Favorite

T cell-based therapies for EBV-associated malignancies

By Taylor Graham S  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 1, 2004-01 ,pp. : 11-21

Informa Healthcare

Access to resources Recommend Favorite

Adoptive T-cell therapy for the treatment of solid tumours

By Knutson Keith L   Almand Bond   Mankoff David A   Schiffman Kathy   Disis Mary L  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 1, 2002-01 ,pp. : 55-66

Informa Healthcare

Access to resources Recommend Favorite

T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy

By Bobisse Sara   Zanovello Paola   Rosato Antonio  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 6, 2007-06 ,pp. : 893-906

Informa Healthcare

Access to resources Recommend Favorite

Current status of adoptive immunotherapy of malignancies

By Morse Michael A   Clay Timothy M   Lyerly H Kim  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 3, 2002-03 ,pp. : 237-247

Informa Healthcare

Access to resources Recommend Favorite